Zionsville, IN, United States of America

Robert J Cregge


 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Zionsville, IN (US) (1983 - 1994)
  • Loveland, OH (US) (1995 - 1996)

Company Filing History:


Years Active: 1983-1996

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Robert J Cregge

Introduction: Robert J Cregge, an accomplished inventor based in Zionsville, Indiana, has made significant contributions to the field of pharmaceutical research and development. With a portfolio of nine patents, his innovations particularly resonate within the domains of drug design and enzyme inhibition.

Latest Patents: Among his notable inventions, Robert's latest patents focus on "Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase." This advancement presents novel aminoacetylmercapto derivatives that can effectively inhibit enkephalinase and angiotensin-converting enzyme (ACE). These inventions hold potential for therapeutic applications, indicating a promising direction for future pharmacological treatments.

Career Highlights: Robert J Cregge has had a fruitful career, working with esteemed companies such as Merrell Dow Pharmaceuticals and The Dow Chemical Company. His experience in these leading organizations has undoubtedly shaped his expertise and contributed to his innovative capabilities in the field.

Collaborations: Throughout his career, Robert has collaborated with distinguished professionals, including coworkers Gary A Flynn and Thomas L Fevig. These partnerships have likely fostered a creative environment that leads to groundbreaking inventions and developments.

Conclusion: Robert J Cregge’s work continues to inspire innovation within the pharmaceutical industry. His extensive experience and notable patents serve as a testament to the impact that dedicated inventors can have on advancing science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…